Aleta Biotherapeutics and Cancer Research UK Collaborate to Advance Blood Cancer Therapy
Aleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a partnership to advance the early phase clinical development of Aleta’s
Read moreAleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a partnership to advance the early phase clinical development of Aleta’s
Read moreThe award-winning Contract Research Organisation (CRO) Altasciences will initiate a Phase I Study in healthy normal subjects for ST-2427, a
Read moreThe COVID-19 treatment XAV-19, developed by French biotech company XENOTHERA, has started a European clinical trial in partnership with Contract
Read moreBristol Myers Squibb announced positive results from a Phase 3 Trial, which showed that neoadjuvant treatment with three cycles of
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read moreJohnson & Johnson has started vaccinating teens aged 12 to 17 in the ongoing Phase 2a clinical trial for its
Read moreNew data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read moreCureVac intends to expand its COVID-19 vaccine candidate clinical trial in order to be able to determine efficacy for select
Read moreJohnson & Johnson announced today that the single-dose COVID-19 vaccine candidate developed by Janssen Pharmaceuticals showed 66% efficacy overall in
Read moreRoche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read more